TABLE 2.

MIC distribution of Lodderomyces elongisporus strains isolated in the present outbreak including clinical and inanimate sources along with strains obtained from other sources against 10 antifungal drugs using CLSI-broth microdilution method

L. elongisporus (no. of isolates)	MIC range (mg/L)a
	FLU	ITC	VRC	ISA	POS	AMB	MFG	AFG	5-FC
Clinical, bloodstream isolates (n = 13)	0.25–1	0.03–0.25	<0.03–0.06	<0.015	<0.015–0.125	0.125–0.5	<0.015–0.125	<0.015–0.5	0.06–0.25
Inanimate environment, NICU (neonate warmer; n = 2)	0.5	0.03–0.06	<0.03	<0.015	<0.015	0.25	<0.015	<0.015–0.5	0.06
Inanimate environment of two hospitals, Delhi (floor; n = 3)b	0.5	0.03–0.06	<0.03	<0.015	<0.015	0.25	<0.015	<0.015–0.5	0.06
Strains from surfaces of apples (n = 13)c	2–4	0.25	0.03–0.12	<0.015	0.06–0.5	0.01–0.5	0.01	0.01–0.5	0.06–0.12

^aFLU, fluconazole; ITC, itraconazole; VRC, voriconazole; ISA, isavuconazole; POS, posaconazole; AMB, amphotericin B; MFG, micafungin; AFG, anidulafungin; 5FC, flucytosine.

^bTwo strains obtained in the previous study (16).

^cStrains obtained in the previous study (14).